APEX’10 PE/VC summit on Feb 4 in Mumbai to focus on healthcare, life sciences
The APEX ’10 Private Equity & Venture Capital Summit organised by Venture Intelligence, a division of the Chennai-based TSJ Media Pvt. Ltd. on February 4 in Mumbai will be featuring a high power panel discussion on the role of private equity and venture capital in healthcare & life sciences. Venture Intelligence is a leading provider of data and analysis on private equity/venture capital and M&A deals in India.
Speakers on the panel include Hari Buggana, MD, Evolvence India Life Sciences Fund,Dr. Bala Manian, CEO, ReaMetrix,Swapan Bhattacharya, MD, TCG Lifesciences,Chetan Tamhankar, CEO, SIRO Clinpharm,S. Nandakumar, CEO, Perfint Healthcare and Amit Mookim, Director, KPMG India
“The mega Ranbaxy-Daiichi deal, which has been followed by other large M&A deals in the pharma sector including the Orchid-Hospira and Shantha-Sanofi deals, has created much excitement among investor community. Consolidation in the hospitals sector is also presenting investors with several interesting investment opportunities,” said Arun Natarajan, managing director & CEO of Venture Intelligence.
However, PE/VC firms also have some specific concerns relating to investments in the HLS industry. A recent poll by Venture Intelligence lists long gestation periods, scalability and talent shortage as among the top concerns for investors when it comes to the healthcare sector. In the life sciences segment, investors’ concerns are focused on the high risk of failure , stiff competition from inside and outside India, as well as patent-related issues. Lack of clarity in regulations and corporate governance standards were listed as common concerns across the industry. The HLS panel at APEX’10 will focus on both the opportunities and challenges for investing in this industry.
Benefits of participating at APEX summit include face-to-face interaction with leading private equity / venture capital investors, learning from leading PE/VC backed entrepreneurs on their experience with raising funding,networking with other entrepreneurs and leading intermediaries who assist in fund raising,opportunity to be part of the 'Company Showcase' manual which will be mailed to leading PE/VC firms, consultants & investment banks.
For participation details, email info@ventureintelligence.in or +91-44-45534303.More information about APEX ’10 is available at http://ventureintelligence.in/ev040210.htm
Speakers on the panel include Hari Buggana, MD, Evolvence India Life Sciences Fund,Dr. Bala Manian, CEO, ReaMetrix,Swapan Bhattacharya, MD, TCG Lifesciences,Chetan Tamhankar, CEO, SIRO Clinpharm,S. Nandakumar, CEO, Perfint Healthcare and Amit Mookim, Director, KPMG India
“The mega Ranbaxy-Daiichi deal, which has been followed by other large M&A deals in the pharma sector including the Orchid-Hospira and Shantha-Sanofi deals, has created much excitement among investor community. Consolidation in the hospitals sector is also presenting investors with several interesting investment opportunities,” said Arun Natarajan, managing director & CEO of Venture Intelligence.
However, PE/VC firms also have some specific concerns relating to investments in the HLS industry. A recent poll by Venture Intelligence lists long gestation periods, scalability and talent shortage as among the top concerns for investors when it comes to the healthcare sector. In the life sciences segment, investors’ concerns are focused on the high risk of failure , stiff competition from inside and outside India, as well as patent-related issues. Lack of clarity in regulations and corporate governance standards were listed as common concerns across the industry. The HLS panel at APEX’10 will focus on both the opportunities and challenges for investing in this industry.
Benefits of participating at APEX summit include face-to-face interaction with leading private equity / venture capital investors, learning from leading PE/VC backed entrepreneurs on their experience with raising funding,networking with other entrepreneurs and leading intermediaries who assist in fund raising,opportunity to be part of the 'Company Showcase' manual which will be mailed to leading PE/VC firms, consultants & investment banks.
For participation details, email info@ventureintelligence.in or +91-44-45534303.More information about APEX ’10 is available at http://ventureintelligence.in/ev040210.htm
Posts
No comments:
Post a Comment